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Cell Biology
Increased conversion of phosphatidylinositol to phosphatidylinositol
phosphate in Dictyostelium cells expressing a mutated ras gene
(inositol/cyclic AMP/oncogene/guanine nucleotide-binding protein)
JEROEN VAN DER KAAY, RICHARD DRAIJER, AND PETER J. M. VAN HAASTERT
Department of Biochemistry, University of Groningen, Nijenborgh 16 9747 AG Groningen, The Netherlands
Communicated by J. T. Bonner, September 4, 1990
ABSTRACT Dictyostelium discoideum cells that overex-
press a ras gene with a Gly12 -- Thr'2 mutation (Dd-ras-Thr12)
have an altered phenotype. These cells were labeled with
[3lHlinositol and the incorporation of radioactivity into inositol
1,4,5-trisphosphate [Ins(1,4,5)P3] was analyzed and found to
be higher than in control cells. In contrast, the total mass of
Ins(1,4,5)P3, as assessed with an assay using a specific
Ins(1,4,5)P3-binding protein, was not significantly different
between control and Dd-ras-Thr12 cells. Cells were labeled with
[3lHJinositol and the incorporation of radioactivity in all inositol
metabolites was analyzed. Increased levels of radioactivity
were observed for phosphatidylinositol phosphate (PtdlnsP),
phosphatidylinositol bisphosphate (PtdInsP2), Ins(1,4,5)P3,
inositol 1,4-bisphosphate, inositol 4,5-bisphosphate, and inosi-
tol 4-monophosphate in Dd-ras-Thr12 cells relative to control
cells. Decreased levels were found for phosphatidylinositol
(Ptdlns) and inositol 1-monophosphate. Calculations on the
substrate/product relationships [i.e., Ins(1,4,5)P3/PtdInsP2]
demonstrate that the observed differences are due only to the
increased conversion of PtdIns to PtdInsP; other enzyme
reactions, including phospholipase C, are not significantly
different between the cell lines. The activity of PtdIns kinase in
vitro is not different between Dd-ras-Thr12 and control cells,
suggesting that either the regulation of this enzyme is altered or
that the translocation of substrate from the endoplasmic retic-
ulum to the kinase in the plasma membrane is modified. The
results suggest multiple metabolic compartments of
Ins(1,4,5)P3 in Dictyostelium cells. In Dd-ras-Thr'2 transfor-
mants the increased conversion of Ptdlns to PtdInsP leads to
increased levels of Ins(1,4,5)P3 in the compartment with a high
metabolic turnover. This Ins(1,4,5)P3 compartment is sug-
gested to be involved in the regulation of cytosolic Ca2+ levels.
Mutations in the ras gene are often found in cancer cells (1),
suggesting that the Ras protein may play a crucial role in the
regulation of cell growth and differentiation. The Ras protein
is a 21-kDa GTP-binding protein that is highly conserved
from yeast and Dictyostelium to mammals (2). Its GTP-
binding and GTPase activities suggest that the Ras protein
belongs to the family of guanine nucleotide-binding proteins
(G proteins) that are involved in signal transduction. This
supposition is strengthened by the fact that oncogenic mu-
tations result in reduced GTPase activity; in G proteins this
would lead to permanent activation and aberrant sensory
transduction.
The large family of GTP-binding proteins may be subdi-
vided into two families: (i) heterotrimeric G proteins involved
in signal transduction (3) and (ii) monomeric GTP-binding
proteins of 18-25 kDa (4). In contrast to signal-transducing G
proteins, the small monomeric G proteins are not directly
activated by surface receptors, and their regulation is as yet
largely unknown. The protein that activates the GTPase
activity in Ras (5, 6) or the protein that increases the
dissociation ofGDP from Ras (7) could provide the important
regulation.
Some members of the family of monomeric GTP-binding
proteins are involved in membrane and organelle trafficking
(8); the function of the Ras protein, however, is still largely
unknown. In yeast, Ras is clearly involved in the regulation
of adenylate cyclase activity (9), but this does not appear to
be the case in Dictyostelium (10) or mammals (11). In these
organisms it was suggested that Ras could be the G protein
that activates phospholipase C (12, 13). Although the expres-
sion of mutated Ras indeed affects D-myo-inositol 1,4,5-
trisphosphate [Ins(1,4,5)P3] levels in many organisms (12-
15), the hypothesis that Ras is the signal-transducing G
protein that mediates receptor stimulation of phospholipase
C has been abandoned (16, 17). The mechanism by which Ras
affects Ins(1,4,5)P3 levels has yet to be demonstrated.
Dictyostelium cells contain two genes that are highly
homologous with mammalian ras, one gene expressed during
growth and one expressed during differentiation (18, 19). Cell
lines have been constructed in which the development-
related ras gene (Dd-ras) was overexpressed (10). Overex-
pression of the wild-type gene has essentially no effect,
whereas overexpression of an oncogene-like Gly12 -+ Thr12
mutation leads to an aberrant phenotype (10).
The social amoebae Dictyostelium grow on bacteria. Star-
vation induces cell aggregation that is mediated by chemo-
taxis to secreted cAMP. The extracellular cAMP signal is
transduced by a complex pathway, involving surface recep-
tors, G proteins, and the second messengers cAMP, cGMP,
Ins(1,4,5)P3, and Ca2+. The tip of the multicellular structure
is thought to be an organizer that regulates cell differentiation
yielding only two cell types, dead stalk cells and viable spores
(20-22). Mutant cell lines that overexpress the Dd-ras-Thr12
gene form multiple tips in submerged cultures (10). The
activation of adenylate cyclase is essentially normal (10, 23),
but the cAMP-mediated activation of guanylate cyclase is
altered, presumably by an enhanced desensitization (23).
Other effects of overexpression of the Dd-ras-Thr'2 gene
point to the activation of a protein kinase C-like activity (24)
and increased levels of Ins(1,4,5)P3 and inositol hexakisphos-
phate (InsP6) in [3H]inositol-labeled cells (13). The most
simple conclusion would be that phospholipase C in these
cells is activated, yielding increased Ins(1,4,5)P3 levels; this
would lead to elevated Ca2+ concentrations, the activation of
protein kinase C, and the desensitization of guanylate cy-
clase, which is known to be inhibited by Ca2+ ions (25).
Use of a binding-protein assay to measure absolute
Ins(1,4,5)P3 concentrations in Dictyostelium showed that the
mass of Ins(1,4,5)P3 in Dd-ras-Thr12 cells was not different
Abbreviations: G protein, guanine nucleotide-binding protein; Ins,
inositol; Ptdlns, phosphatidylinositol; InsP, inositol phosphate
[number and position of phosphate(s) are indicated as exemplified by
Ins(1,4,5)P3, inositol 1,4,5-trisphosphate].
9197
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
9198 Cell Biology: Van der Kaay et al.
from that in control cells, although the incorporation of
[3H]inositol into [3H]Ins(1,4,5)P3 was increased (26). Similar
observations were made for InsP6: [3H]InsP6 levels are
increased (13), but the mass of InsP6 is not altered (27). This
suggests that the effect of overexpression ofDd-ras-Thr12 on
[3H]Ins(1,4,5)P3 and [3H]InsP6 may be very indirect. There-
fore, we have analyzed all inositol metabolites after labeling
cells with [3H]inositol. The results suggest that [3H]Ins-
(1,4,5)P3 levels are increased, not because phospholipase C
is activated, but because phosphatidyl inositol (PtdIns) is
converted more rapidly to PtdInsP.
MATERIALS AND METHODS
Materials. [3H]Inositol (603 TBq/mmol) and [3H]Ins(1,4,
5)P3 (1.2 TBq/mmol) were obtained from NEN/DuPont, and
[_y-32P]ATP (37 TBq/mmol) was from Amersham. The
Ins(1,4,5)P3-binding protein was isolated from bovine adrenal
glands (28).
Culture Conditions. Dictyostelium discoideum strain AX3
transformed with BS10 vector (control), with vector contain-
ing wild-type ras (Dd-ras-Gly12), or with vector containing
mutant ras (Dd-ras-Thr12) were grown in HL5 medium sup-
plemented with G418 (Sigma) at 20 ,ug/ml as described (10).
Cells were harvested at a density of 1-2 x 106 per ml and
starved for 4 hr at a density of 107 per ml in 10 mM sodium/
potassium phosphate buffer at pH 6.5 (PB).
Cell Labeling with [3H]Inositol and Analysis of Metabolites.
Cells were labeled with [3H]inositol by electroporation as
described (29). In brief, cells were collected, washed by
centrifugation, and resuspended at 2 x 108 per ml in PB with
[3H]inositol at 300 ,uCi/ml (1 ,&Ci = 37 kBq). Two high-
voltage discharges temporarily permeabilized the cells, al-
lowing highly efficient labeling with [3H]inositol (29). Cells
were then washed three times with PB and resuspended at 107
per ml in PB. Aliquots were taken after 30-60 min and
centrifuged, and cells were lysed by a mixture containing 9%
(wt/vol) trichloroacetic acid, 5 mM EDTA, and 50 ,ug of
phytic acid hydrolysate per ml (final concentrations). Sam-
ples were centrifuged and the supernatant was analyzed by
HPLC on a reversed-phase ion-pair system and on a Partisil
SAX column as described (29). The pellets were extracted
with 500 ,u of chloroform/methanol/concentrated hydro-
chloric acid, 20:40:1 (vol/vol). After the addition of 200 ,A of
H20 to induce phase separation, the organic phase was
processed for the analysis of phospholipids by TLC on Silica
60 plates that were developed in chloroform/methanol/
concentrated ammonium hydroxide/water, 90:90:5:22. Ra-
dioactive spots were visualized by EN3HANCE spray
(NEN) and fluorography, followed by scraping of the spots
and quantitative determination by scintillation counting.
PtdIns Kinase. Cells were washed once in PB, once in 136
mM Tris/HCl atpH 7.6 (buffer A), and resuspended at 108 per
ml in this buffer. Cells were lysed by rapid passage through
a Nuclepore filter (pore size, 3 ,m). The kinase reaction
mixture (100 pl) contained buffer A, 1 mM MgCl2, 10 mM
NaF, 25 mM KCI, 0.1 mM ATP, 1 ,uCi of [y-32P]ATP, and 20
Al ofhomogenate (30). After incubation for 0, 30, 60, or 90 sec
the reaction was quenched by the addition of 500 ,l of
chloroform/methanol/concentrated hydrochloric acid,
20:40:1. Phase separation was induced by the addition of 200
1A of H20; the organic phase was washed with 200 pl of 2 M
KCI, dried by a stream of nitrogen, and resuspended in 50 ,ul
of chloroform/methanol, 9:1. The samples were chromato-
graphed on Silica 60 plates in chloroform/methanol/concen-
trated ammonium hydroxide/water, 90:90:5:22. The plates
were exposed to Fuji x-ray film and the radioactivity in the
spots was determined by scintillation counting.
RESULTS
Europe-Finner et al. (13) have demonstrated that Dictyostel-
ium cells expressing a mutated ras gene contain higher levels
of [3H]Ins(1,4,5)P3 than control cells after metabolic labeling
with [3H]inositol. We observed (29) that not all of this
radioactivity may have been [3HJIns(1,4,5)P3; therefore, we
reanalyzed the water-soluble fraction of [3H]inositol-labeled
cells by reversed-phase ion-pair HPLC. The results are in
agreement with previous data that Dd-ras-Thr12 cells contain
elevated [3H]Ins(1,4,5)P3 levels (Table 1). Since previous
data also indicated increased levels of [3H]InsP6 (13) without
an increase of the absolute InsP6 concentration (27), the mass
of Ins(1,4,5)P3 was determined by a sensitive assay using an
Ins(1,4,5)P3-binding protein (26). The absolute Ins(1,4,5)P3
concentration was not significantly different among the three
cell lines (Table 1). Radioactive inositol apparently is metab-
olized more actively to Ins(1,4,5)P3 and InsP6 in Dd-ras-Thr12
cells, without significant effects on their respective masses.
Therefore, all inositol-containing metabolites were analyzed
after a short labeling period with [3H]inositol.
Cells were briefly labeled with [33H]inositol and incubated
for 30-60 min to allow the [3H]inositol to be metabolized.
Then, cells were extracted, and the phospholipids were
analyzed by TLC and the water-soluble inositol phosphates
by ion-exchange and ion-pair HPLC (29) (Table 2). The
uptake of [3H]inositol was not significantly different among
the three cell lines (data not shown). However, the distribu-
tion among the various metabolites was quite different, with
the transformant overexpressing the wild-type gene showing
data that were usually between those of control cells and
those of the transformant overexpressing the mutated gene;
we will describe the data of Dd-ras-Thr'2 relative to control
cells. The radioactivities of PtdIns and InslP were signifi-
cantly lower in Dd-ras-Thr12 cells than in control cells. In
contrast, the radioactivities of PtdInsP, PtdInsP2, Ins4P,
Ins(1,4)P2, Ins(4,5)P2, and Ins(1,4,5)P3 were all significantly
higher in Dd-ras-Thr12 cells than in control. Fig. 1 shows a
fluorogram of [3H]inositol-containing phospholipids, demon-
strating the increased labeling of PtdInsP and PtdInsP2. We
also observed several unidentified spots that are tentatively
addressed as lyso-PtdIns and PtdInsY; the labeling of these
spots was not significantly different between control and
Dd-ras-Thr12 cells (Table 2). The observation that the in-
creased incorporation of radioactivity is not restricted to
Ins(1,4,5)P3 but also present in inositolphospholipids sug-
gests that the expression of mutated ras may affect an
enzyme in the inositol cycle other than phospholipase C.
Table 1. Mass and radioactivity of Ins(1,4,5)P3 per 107 cells
Value
Quantity AX3 Dd-ras-Gly12 Dd-ras-Thr12
Ins(1,4,5)P3 mass, pmol 18.3 ± 2.0 15.8 ± 2.4 14.8 ± 1.8
Ins(1,4,5)P3 label, cpm 475 ± 33 713 ± 150* 735 ± 171*
Inositol label, cpm 30,350 ± 2150 33,875 ± 2200 32,100 ± 1850
The mass of Ins(1,4,5)P3 was determined by a binding-protein assay (26). The radioactivity of[3H]Ins(1,4,5)P3 was determined after labeling of the cells with 15 ,.Ci of [3H]inositol and extraction
of the water-soluble products. The analysis was done by reversed-phase ion-pair HPLC.
*, Significantly different from control (AX3) at P > 0.05 (n = 4).
Proc. Natl. Acad. Sci. USA 87 (1990)
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Table 2. [3H]Inositol metabolites in control and ras-transformed cells
Fraction of incorporated radioactivity, %
Compound AX3 Dd-ras-Gly12 Dd-ras-Thr12
Inositol 23.02 ± 1.64 23.26 ± 1.51 (101 ± 10, NS) 25.42 ± 1.46 (110 ± 10, NS)
GroPIns 0.32 ± 0.03 0.28 ± 0.02 (88 ± 10, NS) 0.43 ± 0.07 (134 ± 25, *)
InsIP 2.51 ± 0.27 2.13 ± 0.30 (85 ± 15, NS) 1.59 ± 0.40 (63 ± 17, t)
Ins4P 0.50 ± 0.07 0.61 ± 0.09 (122 ± 25, NS) 0.86 ± 0.12 (172 ± 34, t)
Ins(1,4)P2 0.55 ± 0.12 1.00 ± 0.14 (180 ± 47, *) 1.10 ± 0.14 (200 ± 51, t)
Ins(4,5)P2 0.44 ± 0.09 0.63 ± 0.12 (143 ± 40, NS) 0.76 ± 0.16 (173 ± 51, *)
Ins(1,4,5)P3 0.36 ± 0.07 0.54 ± 0.12 (151 ± 44, *) 0.58 ± 0.13 (162 ± 48, *)
IlnsPx 13.58 ± 0.49 15.58 ± 0.52 (115 ± 6, t) 18.05 ± 1.37 (133 ± 11, t)
Ptdlns 39.40 ± 0.63 34.21 ± 0.93 (87 ± 3, t) 31.11 ± 1.13 (79 ± 3, t)
PtdlnsP 1.22 ± 0.17 2.01 ± 0.35 (165 ± 37, *) 2.73 ± 0.19 (224 ± 35, t)
PtdInsP2 1.44 ± 0.17 1.89 ± 0.47 (131 ± 36, *) 2.47 ± 0.21 (171 ± 25, t)
"Lyso-Ptdlns" 3.40 ± 1.16 4.70 ± 1.32 (138 ± 61, NS) 3.48 ± 2.09 (102 ± 70, NS)
PtdlnsY 3.00 ± 1.16 2.27 ± 0.79 (76 ± 40, NS) 2.61 ± 1.02 (87 ± 48, NS)
Cells were labeled with 15 jiCi per sample, incubated for 30-60 min, and extracted for the analysis
of water-soluble products by HPLC and phospholipids by TLC. InsP" denotes the unidentified peak
that is eluted at the end of the reversed-phase HPLC column (29) and could be InsP6 (13).
"Lyso-Ptdlns" and PtdInsY are spots on the TLC chromatogram that are tentatively or not identified
(see Fig. 1). Gro, glycerol. The radioactivity in the various compounds was determined and the
percentage of the total was calculated. In parentheses, the radioactivity in each compound of the
transformed cells is given as a percentage of the radioactivity in the same compound of control cells;
NS, not significantly different from 100%; *, t, and t, significantly different from 100% at P < 0.05,
P < 0.01, and P < 0.001, respectively (paired t test with n = 4).
The relationship between substrate and product was cal-
culated for each step of the inositol cycle in Dictyostelium.
The data should not be used to calculate relative enzyme
activities, because each metabolite takes part in at least two
enzyme reactions; however, this method may provide evi-
dence for the enzyme reaction that is most strongly altered by
the ras mutation. The inositol cycle that was used for this
purpose (Fig. 2) was derived from combining experiments on
the metabolism of Ins(1,4,5)P3 in vitro (31) with experiments
on the dynamics by which these compounds are labeled after
-FRONT -
a pulse-chase with [3H]inositol in vivo (unpublished obser-
vations). The calculations show (Table 3 and Fig. 2) that the
PtdInsP2/Ins(1,4,5)P3 ratio is not altered in Dd-ras-Thr12
cells relative to control cells, suggesting that phospholipase
C activity is not strongly affected by overexpression of the
mutated ras gene. The same conclusion is reached for all
other reactions, with the exception of the conversion of
PtdIns to PtdInsP, which appears to be about 3-fold faster in
Dd-ras-Thr12 cells than in control cells. These data strongly
suggest that [3H]Ins(1,4,5)P3 levels are higher because Ptd-
InsP2 levels are higher, which is due to elevated levels of
[3H]PtdInsP. The situation for the inositol monophosphate is
especially instructive: InslP levels are decreased because
[3H]PtdIns is low, whereas Ins4P levels are increased be-
cause radioactivities of Ins(1,4)P2 and Ins(4,5)P2 are ele-
vated. Thus, the effect of overexpression of a mutated ras
jE ]PtdInsY -
* _ PtdIns _ qv _ v
op-1 = LysoPtdins C
















FIG. 1. TLC of inositolphospholipids extracted from control
(AX3) and Dd-ras-Thr12 cells. Cells were labeled with [3H]inositol,
and phospholipids were extracted, separated by TLC, and visualized
by fluorography. Spots were identified by cochromatography with
authentic standards. Several unidentified spots are indicated as
lyso-Ptdlns and PtdlnsY. Two exposure times (6 and 40 hr) are
shown.
FIG. 2. Inositol cycle of D. discoideum. The inositol cycle of
Dictyostelium was unraveled by analysis of Ins(1,4,5)P3 degradation
in vitro and of [3H]inositol metabolites after a pulse-chase experi-
ment (29, 31). The radioactivity in the metabolites is increased or
decreased in Dd-ras-Thr12 cells relative to control cells. Numbers
indicate the product/substrate ratio of the reaction of Dd-ras-Thr12
cells relative to this ratio in control cells; starred values are signif-
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Table 3. Balance of inositol phosphates
Product/substrate ratio (% of AX3)
Substrate Product AX3 Dd-ras-Gly12 Dd-ras-Thr12
Ptdlns InslP 0.064 ± 0.007 0.062 ± 0.009 (98 ± 18, NS) 0.051 ± 0.013 (80 ± 20, NS)
PtdlnsP Ins(1,4)P2 0.451 ± 0.117 0.498 ± 0.111 (110 ± 38, NS) 0.403 ± 0.058 (89 ± 26, NS)
PtdInsP2 Ins(1,4,5)P3 0.250 ± 0.057 0.270 ± 0.100 (108 ± 47, NS) 0.2% ± 0.058 (119 ± 36, NS)
Ins(1,4,5)P3 Ins(1,4)P2 1.528 ± 0.446 1.961 ± 0.604 (128 ± 54, NS) 1.507 ± 0.330 (99 ± 36, NS)
Ins(1,4,5)P3 Ins(4,5)P2 1.222 ± 0.345 1.235 ± 0.413 (101 ± 44, NS) 1.041 ± 0.283 (86 ± 34, NS)
Ins(1,4)P2 Ins4P 0.909 ± 0.236 0.610 ± 0.124 (67 ± 22, *) 0.782 ± 0.147 (86 ± 27, NS)
lns(4,5)P2 Ins4P 1.136 ± 0.281 0.968 ± 0.233 (85 ± 29, NS) 1.132 ± 0.286 (100 ± 35, NS)
InslP Ins 9.17 ± 1.18 10.92 ± 1.69 (119 ± 24, NS) 15,99 ± 4.33 (174 ± 52, *)
Ins4P Ins 46.04 ± 7.23 38.13 ± 7.10 (83 ± 20, NS) 29.56 ± 4.46 (64 ± 14, t)
Ins Ptdlns 1.712 ± 0.125 1.471 ± 0.104 (86 ± 9, *) 1.224 ± 0.083 (72 ± 7, t)
Ptdlns PtdInsP 0.031 ± 0.004 0.059 ± 0.010 (190 ± 40, t) 0.088 ± 0.007 (284 ± 43, i:)
PtdlnsP PtdInsP2 1.180 ± 0.216 0.940 ± 0.285 (80 ± 28, NS) 0.905 ± 0.099 (77 ± 16, *)
The ratio of radioactivity in substrate and product was calculated for each step of the inositol cycle that has been
demonstrated to exist. Although this calculation cannot be used as a measure of enzyme activity, it allows one to identify
the enzyme reaction that is different in the Dd-ras-Thr12 cells. See Table 2 for original data and Fig. 2 for the inositol cycle
in Dictyostelium. NS, not significantly different from 100%; *, t, and 4, significantly different from 100%c at P < 0.05, P
< 0.01, and P < 0.001, respectively (paired t test with n = 4).
gene on the inositol cycle can be traced to the conversion of
PtdIns to PtdInsP.
The activity of Ptdlns kinase (as well as PtdInsP kinase) is
demonstrated in Fig. 3, showing the phosphorylation of
membrane phospholipids in a cell-free system. The results
show no significant difference among the three cell lines that
contain the transformation vector, suggesting that overex-
pression of the wild-type or mutant ras gene apparently has
no effect on the activity of Ptdlns kinase.
DISCUSSION
The balance of [3H]inositol metabolites in Dictyostelium cells
expressing a mutant ras oncogene was analyzed because
previous data demonstrated that radioactivity of InsP6 was
increased whereas the mass ofInsP6 was not changed in these
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FIG. 3. PtdIns kinase activity. Membranes from control cells
(AX3) and from cells overexpressing the wild-type (Dd-ras-Giy'2) or
mutant (Dd-ras-Thr'2) gene were incubated with [y-2PIATP. The
phospholipids were analyzed by TLC, and the compounds were
identified by cochromatography with authentic standards. PA, phos-
phatidic acid. Membranes from the bacterially grown wild-type strain
NC4 were also used in this experiment for comparison with previous
experiments (30).
Ins(1,4,5)P3: the mass was not altered, but more radioactivity
was found in this compound after Dd-ras-Thr12 cells were
labeled with [3H]inositol. The balance of inositol metabolites
demonstrates that the underlying mechanism of increased
[3H]Ins(1,4,5)P3 levels is not provided by the enzymes that
synthesize or degrade this compound but is provided by a
more distal reaction, the conversion of PtdIns to PtdlnsP.
The relative incorporation of radioactivity in all other inositol
metabolites can be accounted for by this increased conver-
sion. Thus, there is no reason to propose that increased levels
of [3H]Ins(1,4,5)P3 are due to increased activity of phospho-
lipase C. Other reports confirm a possible role of Ras in the
regulation of PtdIns kinase activity. Huang et al. (32) found
that PtdIns and PtdInsP kinase activities are increased in
membranes from ras-transformed fibroblasts. Microinjection
of Xenopus laevis oocytes with p21 Ras proteins leads to
enhanced PtdIns kinase activity, which is primary to in-
creases in PtdInsP2 and inositol polyphosphate and results in
a decrease in PtdIns (33).
The discrepancy between mass and radioactivity in
Ins(1,4,5)P3 is not easily explainable. It is unlikely that this
is due to differqnces in the specific activity of inositol, since
the relativv level of [3H]inositol is not altered in Dd-ras-Thr12.
This suggests that there may be two pools of Ins(1,4,5)P3; a
small, rapidly labeled pool that is increased in Dd-ras-Thr'2
cells and a large, slowly labeled pool that is unaltered. That
two pools of Ins(1,4,5)P3 may exist is suggested by the
extreme high basal mass of Ins(1,4,5)P3, yielding a mean
concentration of at least 3 ,M, whereas the Ins(1,4,5)P3
receptor involved in Ca2' release has an apparent dissocia-
tion constant of <0.1 AM. Additional support for two distinct
metabolic and functional pools of inositol metabolites was
provided by Gascard et al. (34), who demonstrated phospho-
lipase C-sensitive and -resistant pools of PtdInsP and Ptd-
InsP2 in human erythrocytes. The phospholipase C-sensitive
pool was more actively metabolized by kinases and phos-
phatases than the insensitive pool; it is expected that the
small phospholipase C-sensitive pool is involved in signal
transduction. If two pools of Ins(1,4,5)P3 exist in Dictyo-
stelium, then it is likely that in Dd-ras-Thr12 cells, the
Ins(1,4,5)P3 concentration is actually elevated in the rapidly
labeling responsive pool and that increased levels of Ca2+ or
protein kinase C could be present even though the total
Ins(1,4,5)P3 mass in the cell is not altered. This hypothesis is
supported by previous observations suggesting elevated lev-
els of Ca2+ and protein kinase C activity in Dd-ras-Thr12
transformants (23, 24).
Proc. Natl. Acad Sci. USA 87 (1990)
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Several explanations can account for the enhanced con-
version of PtdIns to PtdlnsP. Altered conformation and/or
levels ofthe PtdIns kinase seem unlikely because we have not
found differences in enzyme activities in vitro among the
three cell lines. For the same reason, direct regulation of the
enzyme by Ras seems unlikely. In mammalian cells the
Ptdlns kinase is present predominantly in the plasma mem-
brane, whereas PtdIns is synthesized mainly in the endoplas-
mic reticulum. Therefore, increased PtdInsP formation in
ras-transformed cells could be due to increased substrate
availability if PtdIns is translocated more actively from the
endoplasmic reticulum to the plasma membrane. Alterna-
tively, in mammalian cells PtdIns kinase activities have been
found in both the endoplasmic reticulum and the plasma
membrane (35), again suggesting the existence of two inde-
pendent metabolic inositol phospholipid pools. Therefore, in
ras-transformed cells there could be increased PtdIns kinase
activity or substrate availability in only one of these meta-
bolic pools.
For the inositol cycle in D. discoideum we have tentatively
identified the principal effect of mutated ras as the increased
conversion of PtdIns to PtdInsP. This conversion is a rela-
tively complex reaction and has not been well analyzed in
Dictyostelium. The mechanism by which Ras proteins inter-
fere with the formation of PtdInsP needs further investiga-
tion. The present results imply that different metabolic and
functional pools of inositolphospholipids have to be consid-
ered.
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